Abstract
This review article discusses the diagnosis and management of hereditary ovarian cancer and hereditary uterine cancer. The key recommendations highlighted are: All women with high grade non-mucinous epithelial ovarian cancer should be offered at least BRCA1 and BRCA2 genetic testing. The care of women with BRCA-associated ovarian cancer should be tailored to their mutation status. Risk-reducing bilateral salpingo-oophorectomy is recommended for women with BRCA1/2 mutations. Women with endometrial cancer should be assessed for the possibility of Lynch syndrome. Individuals with Lynch syndrome should undergo screening colonoscopy every 1–2 years. Lynch syndrome causes a high risk of endometrial cancer, and women with Lynch syndrome should consult with a gynecologic specialist to formulate a plan for managing this risk.
Original language | English (US) |
---|---|
Pages (from-to) | 543-547 |
Number of pages | 5 |
Journal | Seminars in oncology |
Volume | 43 |
Issue number | 5 |
DOIs | |
State | Published - Oct 1 2016 |
Keywords
- BRCA1/2
- Endometrial cancer
- Hereditary cancer
- Lynch syndrome
- Ovarian cancer
ASJC Scopus subject areas
- Hematology
- Oncology